Two conflicting guidelines on prostate specific antigen screening in Japan
Japanese Journal of Clinical Oncology · 2023
DOI: 10.1093/jjco/hyac192 ↗Kurz gefasst
Leitlinie in der Zeitschrift Japanese Journal of Clinical Oncology, 2023. Verfasst von Takeshi Takahashi. Beteiligte Einrichtung: Health and Welfare Bureau, Kitakyushu City Office, Jyonai 1-1, Kitakyushu, Japan. Hauptthemen laut MEDLINE: Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Japanese urologists need to listen seriously to the opinions of public health physicians and it is necessary to properly inform people of prostate specific antigen screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health and Welfare Bureau, Kitakyushu City Office, Jyonai 1-1, Kitakyushu, Japan.
ORCID-Profile: Takeshi Takahashi
Zitieren
APA
Takahashi, T. (2023). Two conflicting guidelines on prostate specific antigen screening in Japan. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyac192
Vancouver
Takahashi T. Two conflicting guidelines on prostate specific antigen screening in Japan. Japanese Journal of Clinical Oncology. 2023. doi:10.1093/jjco/hyac192
BibTeX
@article{Takahashi2023,
author = {Takahashi, Takeshi},
title = {Two conflicting guidelines on prostate specific antigen screening in Japan},
journal = {Japanese Journal of Clinical Oncology},
year = {2023},
doi = {10.1093/jjco/hyac192}
}
EUVIMED